Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

SciClone Bottom Line Stung by Bribery Scandal

By R&D Editors | May 11, 2011

FOSTER CITY, Calif. (AP) – SciClone Pharmaceuticals Inc. said that its first-quarter profit fell 8% on higher costs related to a government investigation alleging bribery to foreign officials in order to secure business overseas.

Meanwhile, the company said it will reduce cash payments for its CEO and that another executive resigned as part of an internal review related to the bribery allegations.

The company earned $3.8 million, or 8 cents per share, down from $4.2 million, or 9 cents per share, during the same period a year prior. Revenue rose 21 percent to $21.7 million from $18 million, while operating expenses rose 32 percent to $14.3 million.

Analysts polled by FactSet expected profit of 5 cents per share on $22.1 million in revenue.

The company’s key revenue driver is the hepatitis B and hepatitis C drug Zadaxin.

The company is currently facing inquiries by the Securities and Exchange Commission and the U.S. Department of Justice about possible violations of anti-bribery laws overseas. The agencies notified the company in August.

SciClone said a special committee at the company found that “appropriate” controls to assure compliance with laws were lacking. It reported its finding to the government agencies. The government investigation is ongoing.

Meanwhile, President and CEO Friedhelm Blobel will not be paid a cash bonus for 2010 and the company will reduce cash incentives, citing the special committee’s findings. That marks a reduction of about $334,000 in cash compensation.

Hans Schmid, president of SciClone’s subsidiary SciClone International Ltd., resigned on Monday. He has been with the company since 2001.

Looking ahead, the company expects full-year profit between 52 cents and 57 cents per share, excluding charges mainly related to the buyout of NovaMed in April. It expects revenue between $133 million and $138 million.

Date: May 11, 2011
Source: Associated Press

Related Articles Read More >

PerkinElmer participating at Bio-IT World Conference & Expo
Nalu Medical’s mIPG is focus of Episode 7 of R&D 100 – The Podcast
R&D 100 winner of the day: Portable EnGineered Analytic Sensor with aUtomated Sampling (PEGASUS)
UCLA bioengineers develop new class of human-powered bioelectronics
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2021 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars